VITA 34 AG Profile Avatar - Palmy Investing

VITA 34 AG

VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous…

Medical - Care Facilities
DE, Leipzig [HQ]

Ratios

15 Records · Starting from 2009
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
67.16 63.80 59.13 59.13 59.49 57.12 45.79 52.92 56.26 58.67 62.30 58.11 43.76 3.97 34.52
Profit Margin
3.95 2.06 7.44 -4.26 6.18 7.98 13.97 2.50 -1.68 4.06 6.67 7.22 -13.82 -39.72 -2.42
Operating Margin
1.07 4.38 -2.09 -5.45 10.84 12.26 11.38 4.79 0.70 12.89 16.21 11.86 -10.28 -37.71 -4.95
EPS Growth
134.92 -18.18 161.11 -142.55 235.00 29.63 85.71 -78.46 -164.79 320.51 65.00 6.06 -291.43 -158.21 93.06
Return on Assets (ROA)
1.91 0.95 3.43 -1.58 2.35 2.97 4.52 0.94 -0.52 1.40 2.21 2.48 -2.21 -18.07 -1.18
Return on Equity (ROE)
3.16 1.89 6.03 -2.86 3.97 4.98 8.36 1.73 -1.09 2.81 4.48 4.90 -9.11 -165.98 -7.92
Return on Invested Capital (ROIC)
0.69 1.75 3.51 -2.36 4.02 4.42 6.54 2.71 0.76 3.36 3.75 4.51 -4.41 -56.31 -5.32
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
7.83 10.41 9.17 5.84 0.98 0.68 6.37 4.94 13.18 12.03 11.93 9.07 18.16 18.60 7.07
Debt/Equity
12.93 20.67 16.13 10.57 1.66 1.14 11.78 9.06 27.66 24.26 24.16 17.94 75.04 170.80 47.51
Debt/EBITDA
-258.21 7.02 21.53 -302.23 -96.48 -135.16 17.99 -29.44 239.54 3.74 -31.25 -94.04 -89.00 -72.91 87.58
Debt/Capitalization
11.45 17.13 13.89 9.56 1.63 1.12 10.54 8.31 21.67 19.52 19.46 15.21 42.87 63.07 32.21
Interest Debt per Share EUR
0.96 1.51 1.26 0.81 0.16 0.09 0.96 0.74 2.34 1.80 1.82 1.34 5.64 1.91 0.78
Debt Growth
50.15 56.56 -16.65 -32.79 -83.65 -28.29 1,011.16 -23.16 281.06 -12.60 2.09 -27.22 509.49 -12.81 -23.44
Liquidity
Current Ratio
336.23 136.00 183.19 145.78 210.51 259.33 144.45 148.24 119.69 144.30 153.00 185.06 87.85 59.92 73.37
Quick Ratio
320.40 127.61 170.15 134.50 196.61 251.60 136.09 142.67 113.58 138.53 149.51 180.36 82.65 54.25 67.31
Cash Ratio
173.00 49.46 72.27 62.29 73.95 97.11 41.17 53.87 51.02 88.09 108.14 131.38 52.35 23.77 31.00
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
894.95 980.83 1,197.62 878.20 998.36 1,990.24 1,815.84 2,635.40 1,678.20 1,849.78 2,596.60 2,259.95 484.45 1,701.49 1,481.94
Receivables Turnover
- - - - - - 510.43 490.73 354.94 378.04 351.23 388.62 530.41 626.07 557.50 168.49 371.83 418.68
Payables Turnover
609.84 688.34 1,089.83 475.94 487.22 849.28 581.01 659.98 884.19 762.66 603.00 637.86 212.24 821.81 510.42
Asset Turnover
48.47 46.24 46.06 37.14 38.04 37.20 32.36 37.52 30.96 34.41 33.14 34.33 15.97 45.50 48.66
Coverage
Interest Coverage
98.18 260.70 -130.35 -501.35 1,056.83 5,633.33 3,665.91 1,418.18 100.75 1,235.21 1,793.44 1,307.69 -534.00 -1,269.24 -325.90
Asset Coverage
1,100 600 700 1,100 7,000 10,600 900 1,200 400 400 400 700 300 200 400
Cash Flow Coverage (CFGR)
47.09 26.39 -21.45 95.28 507.14 420.32 92.86 106.72 18.74 64.42 86.71 75.05 8.44 -15.92 82.64
EBITDA Coverage
800 600 200 300 1,900 8,500 8,900 4,100 1,200 2,200 3,100 2,900 100 -700 400
Dividend Coverage
- - - - - - - - - - - - -400 - - - - -100 -200 - - - - - - 26,600
Time Interest Earned (TIE)
100 100 - - - - 100 100 - - 100 100 100 100 100 - - - - - -
Market Prospects
Dividend Yield
- - - - - - - - - - - - 3.12 2.95 1.09 1.46 1.26 - - - - - - 0.01
Earnings Yield
4.97 2.84 16.15 -6.90 8.79 7.28 13.98 2.54 -0.74 1.85 2.58 2.82 -4.49 -22.13 -2.27
Price/Earnings (P/E)
20.1399 35.2515 6.1933 -14.5010 11.3765 13.7417 7.1537 39.3827 -135.5881 54.0101 38.7048 35.4947 -22.2557 -4.5198 -44.1087
Price/Book (P/B)
63.60 66.58 37.36 41.45 45.20 68.48 59.80 67.94 147.87 151.98 173.28 174.03 202.85 750.20 349.13
Price/Sales (P/S)
79.51 72.53 46.10 61.72 70.34 109.65 99.92 98.64 227.56 219.11 258.07 256.26 307.47 179.54 106.75
Price/Cash Flow (P/CF)
1,044.68 1,220.51 -1,079.97 411.77 537.10 1,432.78 546.61 702.59 2,853.55 972.60 827.03 1,292.26 3,204.11 -2,759.16 889.23
End of V3V.DE's Analysis
CIK: - CUSIP: D9506F102 ISIN: DE000A0BL849 LEI: - UEI: -
Secondary Listings
V3V.DE has no secondary listings inside our databases.